National Health Investors (NYSE:NHI – Get Rating) is set to release its earnings data after the market closes on Tuesday, February 21st. Analysts expect National Health Investors to post earnings of $1.10 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
National Health Investors Stock Performance
NHI opened at $58.03 on Tuesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 13.82 and a quick ratio of 13.83. The business has a fifty day simple moving average of $55.62 and a 200 day simple moving average of $57.97. National Health Investors has a 1 year low of $50.22 and a 1 year high of $67.16. The company has a market capitalization of $2.52 billion, a PE ratio of 36.96 and a beta of 0.91.
Analysts Set New Price Targets
Several research firms recently commented on NHI. Credit Suisse Group upgraded shares of National Health Investors from an “underperform” rating to a “neutral” rating and upped their price target for the company from $47.00 to $58.00 in a research note on Friday, December 9th. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Friday, January 6th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $61.25.
Insiders Place Their Bets
In other National Health Investors news, Director Robert G. Adams purchased 1,000 shares of the stock in a transaction dated Wednesday, December 14th. The stock was bought at an average price of $56.60 per share, with a total value of $56,600.00. Following the acquisition, the director now owns 180,548 shares of the company’s stock, valued at $10,219,016.80. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 7.26% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. Hsbc Holdings PLC boosted its stake in shares of National Health Investors by 27.8% during the first quarter. Hsbc Holdings PLC now owns 9,014 shares of the real estate investment trust’s stock valued at $533,000 after purchasing an additional 1,962 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of National Health Investors during the first quarter valued at $4,131,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of National Health Investors by 4.3% during the first quarter. Charles Schwab Investment Management Inc. now owns 638,656 shares of the real estate investment trust’s stock worth $37,688,000 after purchasing an additional 26,611 shares during the period. Edgestream Partners LP acquired a new position in shares of National Health Investors during the first quarter worth $736,000. Finally, Nelson Van Denburg & Campbell Wealth Management Group LLC bought a new stake in shares of National Health Investors in the first quarter worth $447,000. 62.44% of the stock is currently owned by institutional investors.
About National Health Investors
(Get Rating)
National Health Investors, Inc engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes leases, mortgages and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings.
See Also
Receive News & Ratings for National Health Investors Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for National Health Investors and related companies with MarketBeat.com’s FREE daily email newsletter.